ZNF10
gene geneOn this page
Also known as KOX1
Summary
ZNF10 (zinc finger protein 10, HGNC:12879) is a protein-coding gene on chromosome 12q24.33, encoding Zinc finger protein 10 (P21506). May be involved in transcriptional regulation.
The protein encoded by this gene contains a C2H2 zinc finger, and has been shown to function as a transcriptional repressor. The Kruppel-associated box (KRAB) domain of this protein is found to be responsible for its transcriptional repression activity. RING finger containing protein TIF1 was reported to interact with the KRAB domain, and may serve as a mediator for the repression activity of this protein.
Source: NCBI Gene 7556 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 33 total — 1 likely-pathogenic
- MANE Select transcript:
NM_015394
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12879 |
| Approved symbol | ZNF10 |
| Name | zinc finger protein 10 |
| Location | 12q24.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KOX1 |
| Ensembl gene | ENSG00000256223 |
| Ensembl biotype | protein_coding |
| OMIM | 194538 |
| Entrez | 7556 |
Gene structure
Transcript identifiers
Ensembl transcripts: 25 — 21 protein_coding, 3 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000248211, ENST00000402932, ENST00000426665, ENST00000536704, ENST00000536877, ENST00000537119, ENST00000538918, ENST00000540609, ENST00000540927, ENST00000543271, ENST00000869334, ENST00000869335, ENST00000869336, ENST00000869337, ENST00000869338, ENST00000869339, ENST00000869340, ENST00000915347, ENST00000915348, ENST00000915349, ENST00000915350, ENST00000962635, ENST00000962636, ENST00000962637, ENST00000962638
RefSeq mRNA: 1 — MANE Select: NM_015394
NM_015394
CCDS: CCDS9283
Canonical transcript exons
ENST00000248211 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001287780 | 133155503 | 133159465 |
| ENSE00002310325 | 133130627 | 133130754 |
| ENSE00003472870 | 133144434 | 133144525 |
| ENSE00003617170 | 133151028 | 133151154 |
| ENSE00003688266 | 133151809 | 133151904 |
Expression profiles
Bgee: expression breadth ubiquitous, 239 present calls, max score 93.51.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.2660 / max 222.0225, expressed in 1568 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 128859 | 7.5686 | 1464 |
| 128858 | 1.6973 | 850 |
Top tissues by expression
285 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adenohypophysis | UBERON:0002196 | 93.51 | gold quality |
| pituitary gland | UBERON:0000007 | 92.90 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.53 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 89.44 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 89.42 | gold quality |
| thyroid gland | UBERON:0002046 | 88.56 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.89 | gold quality |
| left ovary | UBERON:0002119 | 87.70 | gold quality |
| right uterine tube | UBERON:0001302 | 87.60 | gold quality |
| right ovary | UBERON:0002118 | 86.92 | gold quality |
| body of pancreas | UBERON:0001150 | 86.74 | gold quality |
| mucosa of stomach | UBERON:0001199 | 86.67 | gold quality |
| secondary oocyte | CL:0000655 | 86.45 | gold quality |
| popliteal artery | UBERON:0002250 | 85.95 | gold quality |
| tibial artery | UBERON:0007610 | 85.95 | gold quality |
| body of uterus | UBERON:0009853 | 85.49 | gold quality |
| cortical plate | UBERON:0005343 | 85.46 | gold quality |
| left uterine tube | UBERON:0001303 | 85.40 | gold quality |
| aorta | UBERON:0000947 | 85.10 | gold quality |
| endocervix | UBERON:0000458 | 85.00 | gold quality |
| ovary | UBERON:0000992 | 84.96 | gold quality |
| metanephros cortex | UBERON:0010533 | 84.92 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 84.70 | gold quality |
| thoracic aorta | UBERON:0001515 | 84.26 | gold quality |
| right coronary artery | UBERON:0001625 | 84.25 | gold quality |
| ascending aorta | UBERON:0001496 | 84.23 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 84.13 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 83.55 | gold quality |
| body of stomach | UBERON:0001161 | 83.16 | gold quality |
| calcaneal tendon | UBERON:0003701 | 83.09 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.67 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
1 targets.
| Target | Regulation |
|---|---|
| CD74 |
miRNA regulators (miRDB)
107 targeting ZNF10, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-3134 | 100.00 | 66.43 | 777 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-6793-5P | 99.97 | 65.95 | 758 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-96-5P | 99.95 | 72.80 | 2140 |
| HSA-MIR-3682-5P | 99.93 | 67.97 | 1163 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
Literature-anchored findings (GeneRIF, showing 3)
- Data indicate that Xenopus laevis XFIN-AB displayed reduced potency in repression compared to human ZNF10 KRAB-AB. (PMID:24498343)
- results indicate that ZNF10 could be involved in a potent intrinsic antiretroviral defense (PMID:26096782)
- The KRAB Domain of ZNF10 Guides the Identification of Specific Amino Acids That Transform the Ancestral KRAB-A-Related Domain Present in Human PRDM9 into a Canonical Modern KRAB-A Domain. (PMID:35162997)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF440 (ENSG00000171295), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300)
Protein
Protein identifiers
Zinc finger protein 10 — P21506 (reviewed: P21506)
Alternative names: Zinc finger protein KOX1
All UniProt accessions (5): P21506, F5GZ75, F5H0R3, F5H311, F8WD46
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subunit / interactions. Interacts (via the KRAB domain) with TRIM28 (via the RBCC domain).
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_056209* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13465
UniProt features (17 total): zinc finger region 11, sequence conflict 3, chain 1, domain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P21506-F1 | 63.45 | 0.17 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 71 (showing top):
MORF_ZNF10, HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP, BROWNE_HCMV_INFECTION_10HR_UP, MORF_DCC, chr12q24, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, PDGF_UP.V1_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CEBPZ_TARGET_GENES, E2F5_TARGET_GENES, PAX3_TARGET_GENES, PCGF1_TARGET_GENES, SKIL_TARGET_GENES, ZIM3_TARGET_GENES
GO Biological Process (3): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355), positive regulation of transcription by RNA polymerase II (GO:0045944)
GO Molecular Function (7): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), transcription cis-regulatory region binding (GO:0000976), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), protein-containing complex (GO:0032991)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transcription by RNA polymerase II | 2 |
| regulation of transcription by RNA polymerase II | 2 |
| regulation of DNA-templated transcription | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| positive regulation of DNA-templated transcription | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| transition metal ion binding | 1 |
| transcription regulatory region nucleic acid binding | 1 |
| sequence-specific double-stranded DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular_component | 1 |
Protein interactions and networks
STRING
384 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF10 | TRIM28 | Q13263 | 930 |
| ZNF10 | SETDB1 | Q15047 | 734 |
| ZNF10 | TRIM24 | O15164 | 596 |
| ZNF10 | TRIM33 | Q9UPN9 | 595 |
| ZNF10 | RNF215 | Q9Y6U7 | 584 |
| ZNF10 | TMPRSS12 | Q86WS5 | 544 |
| ZNF10 | GTF3C3 | Q9Y5Q9 | 487 |
| ZNF10 | ERGIC2 | Q96RQ1 | 473 |
| ZNF10 | ZZZ3 | Q8IYH5 | 446 |
| ZNF10 | KMT5B | Q4FZB7 | 424 |
| ZNF10 | KMT5C | Q86Y97 | 424 |
| ZNF10 | TRAT1 | Q6PIZ9 | 396 |
| ZNF10 | ZNF438 | Q7Z4V0 | 392 |
| ZNF10 | KAT8 | Q9H7Z6 | 383 |
| ZNF10 | PRR22 | Q8IZ63 | 367 |
IntAct
13 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF10 | CARD10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF10 | TRIM28 | psi-mi:“MI:0915”(physical association) | 0.550 |
| TRIM28 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF10 | Trim24 | psi-mi:“MI:0915”(physical association) | 0.370 |
| BMI1 | MEIS3P1 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF10 | NES | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF10 | NDEL1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| FMR1 | ZNF10 | psi-mi:“MI:0915”(physical association) | 0.000 |
| NDEL1 | ZNF10 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF10 | CARD10 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (29): TRIM28 (Two-hybrid), TRIM24 (Two-hybrid), ZNF10 (Two-hybrid), TRIM28 (Reconstituted Complex), TRIM28 (Co-purification), ZNF10 (Affinity Capture-Western), USP34 (Affinity Capture-MS), NES (Affinity Capture-MS), SETD2 (Affinity Capture-MS), HDAC6 (Affinity Capture-MS), PACSIN2 (Affinity Capture-MS), SRY (Reconstituted Complex), Sry (Reconstituted Complex), TRIM28 (Reconstituted Complex), ZNF10 (Affinity Capture-Western)
ESM2 similar proteins: A0A1W2PQL4, A0JPL0, A2RRD8, A6NHJ4, A6NP11, B4DX44, O75346, O95780, P0CB33, P21506, P51508, P52738, Q0D2J5, Q0VGE8, Q12901, Q13360, Q14593, Q15973, Q2M218, Q2M3X9, Q2VY69, Q3SXZ3, Q5HY98, Q5RCJ2, Q5VIY5, Q6J6I6, Q7L2R6, Q86XU0, Q86Y25, Q8IW36, Q8IYN0, Q8IYX0, Q8N782, Q8N883, Q8N9Z0, Q8NDP4, Q95K49, Q969W8, Q96H40, Q96N58
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
33 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 20 |
| Likely benign | 3 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 563980 | GRCh37/hg19 12q24.33(chr12:130973400-133777902)x3 | Likely pathogenic |
SpliceAI
1195 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:133144432:A:AG | acceptor_gain | 1.0000 |
| 12:133144433:G:GG | acceptor_gain | 1.0000 |
| 12:133144433:GC:G | acceptor_gain | 1.0000 |
| 12:133144433:GCT:G | acceptor_gain | 1.0000 |
| 12:133144433:GCTT:G | acceptor_gain | 1.0000 |
| 12:133144433:GCTTT:G | acceptor_gain | 1.0000 |
| 12:133144496:GATGC:G | donor_gain | 1.0000 |
| 12:133144524:GG:G | donor_gain | 1.0000 |
| 12:133144525:GG:G | donor_gain | 1.0000 |
| 12:133151021:GTTGT:G | acceptor_loss | 1.0000 |
| 12:133151022:TTGTA:T | acceptor_loss | 1.0000 |
| 12:133151023:TGTA:T | acceptor_loss | 1.0000 |
| 12:133151025:TA:T | acceptor_loss | 1.0000 |
| 12:133151025:TAGAC:T | acceptor_loss | 1.0000 |
| 12:133151026:A:AG | acceptor_gain | 1.0000 |
| 12:133151026:A:AT | acceptor_loss | 1.0000 |
| 12:133151026:A:C | acceptor_loss | 1.0000 |
| 12:133151027:G:GA | acceptor_gain | 1.0000 |
| 12:133151027:GAC:G | acceptor_gain | 1.0000 |
| 12:133151027:GACA:G | acceptor_gain | 1.0000 |
| 12:133151027:GACAC:G | acceptor_gain | 1.0000 |
| 12:133151153:GG:G | donor_gain | 1.0000 |
| 12:133151153:GGGTA:G | donor_loss | 1.0000 |
| 12:133151154:GG:G | donor_gain | 1.0000 |
| 12:133151155:G:GA | donor_loss | 1.0000 |
| 12:133151155:G:GC | donor_loss | 1.0000 |
| 12:133151155:G:GG | donor_gain | 1.0000 |
| 12:133151156:TAAGA:T | donor_loss | 1.0000 |
| 12:133151798:A:AG | acceptor_gain | 1.0000 |
| 12:133151798:ACT:A | acceptor_gain | 1.0000 |
AlphaMissense
3829 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:133156654:T:C | F470L | 0.999 |
| 12:133156656:C:A | F470L | 0.999 |
| 12:133156656:C:G | F470L | 0.999 |
| 12:133156738:T:C | F498L | 0.998 |
| 12:133156740:C:A | F498L | 0.998 |
| 12:133156740:C:G | F498L | 0.998 |
| 12:133156757:T:C | L504P | 0.998 |
| 12:133156234:T:C | F330L | 0.997 |
| 12:133156236:C:A | F330L | 0.997 |
| 12:133156236:C:G | F330L | 0.997 |
| 12:133156402:T:C | F386L | 0.997 |
| 12:133156404:C:A | F386L | 0.997 |
| 12:133156404:C:G | F386L | 0.997 |
| 12:133156505:T:C | L420P | 0.997 |
| 12:133156570:T:C | F442L | 0.997 |
| 12:133156572:T:A | F442L | 0.997 |
| 12:133156572:T:G | F442L | 0.997 |
| 12:133156597:C:G | H451D | 0.997 |
| 12:133156599:T:A | H451Q | 0.997 |
| 12:133156599:T:G | H451Q | 0.997 |
| 12:133156673:T:C | L476P | 0.997 |
| 12:133156685:A:C | Q480P | 0.997 |
| 12:133156577:G:C | R444P | 0.996 |
| 12:133156589:T:C | L448P | 0.996 |
| 12:133156150:T:C | F302L | 0.995 |
| 12:133156152:C:A | F302L | 0.995 |
| 12:133156152:C:G | F302L | 0.995 |
| 12:133156421:T:C | L392P | 0.995 |
| 12:133156527:C:A | H427Q | 0.995 |
| 12:133156527:C:G | H427Q | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000047427 (12:133131470 ATACTGT>A), RS1000080748 (12:133130706 T>G), RS1000134559 (12:133130550 A>C), RS1000192111 (12:133149077 A>AGTT), RS1000228124 (12:133149280 C>T), RS1000333066 (12:133149237 G>A), RS1000391025 (12:133143047 T>A,C), RS1000457215 (12:133155602 A>G,T), RS1000508647 (12:133150593 A>G), RS1000737462 (12:133157183 A>G), RS1000806953 (12:133155250 T>C), RS1000966761 (12:133137844 C>G), RS1001020478 (12:133143795 C>T), RS1001082659 (12:133132034 A>G), RS1001146516 (12:133137036 TC>T)
Disease associations
OMIM: gene MIM:194538 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010002_179 | Refractive error | 1.000000e-12 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
33 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Nickel | decreases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Tobacco Smoke Pollution | decreases expression, increases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | increases methylation | 1 |
| trichostatin A | decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| cupric oxide | increases expression | 1 |
| hydroquinone | decreases expression | 1 |
| avobenzone | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Mercury | decreases expression | 1 |
| Methotrexate | increases expression | 1 |
| Plant Oils | increases expression | 1 |
| Thiram | increases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Vitamin E | decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
Cellosaurus cell lines
2 cell lines: 1 cancer cell line, 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TZ34 | HAP1 ZNF10 (-) | Cancer cell line | Male |
| CVCL_XW00 | HEK293 eGFP-ZNF10 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.